Is PRVA undervalued or overvalued?
As of 2025-03-21, the Intrinsic Value of Privia Health Group Inc (PRVA) is 30.31 USD. This PRVA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 23.64 USD, the upside of Privia Health Group Inc is 28.20%. This means that PRVA is undervalued by 28.20%.
The range of the Intrinsic Value is 20.44 - 74.19 USD
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 20.44 - 74.19 | 30.31 | 28.2% |
| DCF (Growth 10y) | 34.18 - 128.50 | 51.56 | 118.1% |
| DCF (EBITDA 5y) | 20.19 - 23.03 | 21.05 | -10.9% |
| DCF (EBITDA 10y) | 30.49 - 36.20 | 32.47 | 37.4% |
| Fair Value | 0.60 - 0.60 | 0.60 | -97.48% |
| P/E | 3.73 - 10.97 | 7.34 | -69.0% |
| EV/EBITDA | 6.82 - 10.44 | 8.10 | -65.8% |
| EPV | 5.79 - 6.21 | 6.00 | -74.6% |
| DDM - Stable | 1.15 - 3.93 | 2.54 | -89.3% |
| DDM - Multi | 11.73 - 31.82 | 17.23 | -27.1% |
| Market Cap (mil) | 2,848.86 |
| Beta | 0.72 |
| Outstanding shares (mil) | 120.51 |
| Enterprise Value (mil) | 2,357.71 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.99% |
| Cost of Debt | 4.48% |
| WACC | 5.53% |